Skip to Main Content


Mental Health & Behavioral Research, Phase Pilot

Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

What is the purpose of this trial?

The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines, to identify predictors and correlates of response to an accepted first-line pharmacological treatment for obsessive-compulsive disorder.

We need both 40 matched Healthy controls for a single fMRI, as well as 80 Unmedicated participants with OCD for a randomized, double blind OCD treatment trial with 4 fMRI scans over 18 weeks.

Please email or call and leave a message at 1-855-OCD-YALE (1-855-623-9253).

Contact Information

For more information about this study, including how to volunteer, contact Yale OCD Research Clinic

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact, or call 877.978.8343 for more information.

  • Last Updated
  • Study HIC